- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Potential Companies
U.S. Pharmaceuticals & Biotech High Growth Potential Companies
Results
160
Companies with a Future performance score of at least 3, ordered by Future performance score.
160 companies
Revvity
Market Cap: US$10.2b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$90.93
7D
5.9%
1Y
-22.6%
Assertio Holdings
Market Cap: US$79.1m
A pharmaceutical company, provides various products to patients in the United States.
ASRT
US$0.81
7D
10.4%
1Y
-24.1%
Quoin Pharmaceuticals
Market Cap: US$4.2m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$7.18
7D
-2.6%
1Y
-57.3%
Amarin
Market Cap: US$308.2m
A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.
AMRN
US$15.00
7D
-0.3%
1Y
22.6%
Minerva Neurosciences
Market Cap: US$12.3m
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
NERV
US$1.81
7D
0.2%
1Y
-36.0%
Oculis Holding
Market Cap: US$988.2m
A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
OCS
US$18.05
7D
-0.8%
1Y
51.0%
Collegium Pharmaceutical
Market Cap: US$1.2b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$37.86
7D
27.3%
1Y
10.4%
Veracyte
Market Cap: US$2.3b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$30.68
7D
28.0%
1Y
-1.6%
Mesa Laboratories
Market Cap: US$348.1m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$69.28
7D
11.7%
1Y
-43.8%
Processa Pharmaceuticals
Market Cap: US$11.1m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.23
7D
0.2%
1Y
-83.1%
Immunic
Market Cap: US$84.1m
A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
IMUX
US$0.83
7D
-15.3%
1Y
-36.2%
Charles River Laboratories International
Market Cap: US$7.5b
Charles River Laboratories International, Inc.
CRL
US$155.00
7D
3.1%
1Y
-21.9%
Perrigo
Market Cap: US$3.2b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$23.66
7D
0.2%
1Y
-11.9%
Tevogen Bio Holdings
Market Cap: US$186.4m
A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
TVGN
US$1.01
7D
6.0%
1Y
39.3%
Aurinia Pharmaceuticals
Market Cap: US$1.5b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$12.01
7D
3.4%
1Y
114.8%
Atara Biotherapeutics
Market Cap: US$82.4m
Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.
ATRA
US$12.13
7D
6.5%
1Y
57.1%